Future prospect of "Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients"

被引：0
|
作者：
Kang, Yong-Bo [1 ]
Cai, Yue [1 ]
机构：
[1] Shanxi Med Univ, Dept Microbiol & Immunol, Sch Basic Med Sci, Wenhua St, Jinzhong 030600, Shanxi, Peoples R China
来源：
WORLD JOURNAL OF GASTROENTEROLOGY | 2022年 / 28卷 / 20期
关键词：
Gut microbiome; Immunotherapy; Immune checkpoint inhibitor resistance; Probiotics; Faecal microbiota transplantation; Hepatocellular carcinoma; Prognosis;
D O I：
10.3748/wjg.v28.i20.2248
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Recently, we read the article "Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients" with interest, and it is preliminary suggested that gut microbiota is closely related to therapeutic effect of nivolumab. Based on the meaningful results of this article, several valuable research directions are proposed to enhance the therapeutic effect of immune checkpoint inhibitors on advanced hepatocellular carcinoma.
引用
收藏
页码：2248 / 2250
页数：3
相关论文
共 50 条
  • [1] Future prospect of “Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients”
    Yong-Bo Kang
    Yue Cai
    World Journal of Gastroenterology, 2022, (20) : 2248 - 2250
  • [2] Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients
    Chung, Min-Woo
    Kim, Moon-Ju
    Won, Eun Jeong
    Lee, Yu Jeong
    Yun, Yong-Woon
    Cho, Sung Bum
    Joo, Young-Eun
    Hwang, Jun-Eul
    Bae, Woo Kyun
    Chung, Ik-Joo
    Shin, Myung Geun
    Shin, Jong Hee
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (42) : 7340 - 7349
  • [3] Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients
    Min-Woo Chung
    Moon-Ju Kim
    Eun Jeong Won
    Yu Jeong Lee
    Yong-Woon Yun
    Sung Bum Cho
    Young-Eun Joo
    Jun-Eul Hwang
    Woo Kyun Bae
    Ik-Joo Chung
    Myung Geun Shin
    Jong Hee Shin
    World Journal of Gastroenterology, 2021, (42) : 7340 - 7349
  • [4] Association of gut microbiome with clinical response to nivolumab in advanced hepatocellular carcinoma: A pilot study
    Lee, Pei-Chang
    Lee, ChiehJu
    Ho, Hsiu J.
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E89 - E89
  • [5] Gut microbiome composition to predict resistance in renal cell carcinoma (RCC) patients on nivolumab
    Derosa, Lisa
    Iebba, Valerio
    Albiges, Laurence
    Fidelle, Marine
    Bonvalet, Melodie
    Colomba, Emeline
    Zitvogel, Laurence
    Escudier, Bernard
    Routy, Bertrand
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] Gut microbiome can predict chemoradiotherapy efficacy in patients with esophageal squamous cell carcinoma
    Takuma Sasaki
    Yasunori Matsumoto
    Kentaro Murakami
    Satoshi Endo
    Takeshi Toyozumi
    Ryota Otsuka
    Kazuya Kinoshita
    Jie Hu
    Shinichiro Iida
    Hiroki Morishita
    Yuri Nishioka
    Akira Nakano
    Masaya Uesato
    Hisahiro Matsubara
    Esophagus, 2023, 20 : 691 - 703
  • [7] Gut microbiome can predict chemoradiotherapy efficacy in patients with esophageal squamous cell carcinoma
    Sasaki, Takuma
    Matsumoto, Yasunori
    Murakami, Kentaro
    Endo, Satoshi
    Toyozumi, Takeshi
    Otsuka, Ryota
    Kinoshita, Kazuya
    Hu, Jie
    Iida, Shinichiro
    Morishita, Hiroki
    Nishioka, Yuri
    Nakano, Akira
    Uesato, Masaya
    Matsubara, Hisahiro
    ESOPHAGUS, 2023, 20 (04) : 691 - 703
  • [8] Dysbiosis of the gut microbiome in elderly patients with hepatocellular carcinoma
    Weizheng Zhang
    Xiaosong Xu
    Liping Cai
    Xiangsheng Cai
    Scientific Reports, 13
  • [9] Dysbiosis of the gut microbiome in elderly patients with hepatocellular carcinoma
    Zhang, Weizheng
    Xu, Xiaosong
    Cai, Liping
    Cai, Xiangsheng
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [10] PET-MR can predict survival and response in advanced hepatocellular carcinoma patients treated with sorafenib
    Hwang, Jae-Pil
    Lim, Ilhan
    Han, Chul Ju
    Park, Su Cheol
    Kim, Young Han
    Park, Joon Yeun
    Kim, Kyeong Min
    Kim, Byung Il
    Choi, Chang Woon
    Lim, Sang Moo
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
12345